As biomarkers for the tumor microenvironment (TME), CD163 and CD68 (tumor-infiltrating macrophages—TAM), as well as CD34 and CD105 (intratumoral microvascular density—IMVD), were chosen. The gene discussed is CD34; the disease is neoplasm.